Abstract
l-Prolyl- l-leucyl-glycinamide (PLG), also known as melanocyte-stimulating hormone release inhibiting factor (MIF-1), is an endogenous brain tripeptide. Previous studies have shown that PLG, and its peptidomimetic analogues, render dopamine D 2 receptors more responsive to agonists by maintaining the high-affinity binding state of the receptors. In the present study, we examined the effect PLG and its analogue 3( R)-[(2( S)-pyrrolidylcarbonyl)amino]-2-oxo-l-pyrrolidineacetamide (PAOPA) on dopamine-stimulated adenylyl cyclase and NPA-stimulated GTPase activity in rat striatal membranes. Dopamine-stimulated adenylyl cyclase activity was inhibited by both PLG and PAOPA in a dose-dependent manner, whereas R(−)-propylnorapomorphine (NPA)-stimulated low K m GTPase activity was significantly increased by 1 μM PLG or 1 nM PAOPA. These results suggest that PLG and PAOPA maintain the high affinity state of the D 2 receptor by increasing GTP hydrolysis through stimulation of agonist-induced GTPase activity.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
